[1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[2] |
XIE Jingjing, YIN Hongtao, LIU Jinjin, SUN Weiming, ZHEN Donghu.
Baseline serum 25-hydroxyvitamin D3 levels and risk of metabolic syndrome: a prospective cohort study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 641-652.
|
[3] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
[4] |
ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen.
Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
|
[5] |
LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei.
Research progress of virus-mediated gene therapy in type 2 diabetes mellitu
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
|
[6] |
DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian.
Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
|
[7] |
ZHANG Quan, SHI Shiyuan, HAN Guihe.
1,25 dihydroxy vitamin D3 for immunoregulation in the treatment of spinal tuberculosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 787-793.
|
[8] |
ZHANG Dezhi, LIU Meng, ZHU Shaogong, LIU Guiju, JI Jie.
Efficacy and safety of XELOX therapy in comparison with capecitabine monotherapy in adjuvant chemotherapy for elderly patients with colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 926-936.
|
[9] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|
[10] |
YE Shengkai, WEN Jie, LIU Weiping, REN Xia, CHEN Haiying, DU Ying, LI Xue, ZHANG Ru, YU Li, ZHANG Biying.
Effects of dapagliflozin on intima-medial thickness of carotid artery in type 2 diabetic mellitus patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 814-819.
|
[11] |
ZHANG Chunyan, FAN Xiaodong, QIN Yuan, KONG Wenqiang, ZHOU Chunyang, DU Biao.
Markov model to assess long-term effects of teneligliptin in treatment of type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 65-72.
|
[12] |
SONG Meiqing.
Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
|
[13] |
LIU Chang, JIANG Daoli, LIU Xiaofang, XU Jia, WANG Lijue, WANG Qian, XU Ling, FANG Yi.
Establishment of rat model of type 2 diabetes induced by streptozotocin combined with cerebral ischemic reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 518-525.
|
[14] |
NI Yingqun, XIE Fengtao, FANG Zhaohui.
Danzhijiangtang capsule protects vasculopathy of T2DM: an evaluation based on the expression of Wnt/β-catenin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 531-537.
|
[15] |
YOU Kuangzhang, CHEN Bin, BAO Qianqian.
Effect of sevoflurane combined with propofol on postoperative cognitive function and serum oxidative stress level in elderly patients with non small cell lung cancer after thoracic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 190-193.
|